shutterstock_1826477633_hjbc
HJBC / Shutterstock.com
2 August 2022MedtechStaff Writer

Medtech firm faces lawsuit over COVID–19 design

Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.
Big Pharma
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.
Big Pharma
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.

More on this story

Medtech
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.
Big Pharma
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.
Big Pharma
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.

More on this story

Medtech
23 February 2023   California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.
Big Pharma
28 July 2022   German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.
Big Pharma
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.